loader
Please Wait
Applying Filters...
menu
    • menu

    First Subjects Dosing with VS-041 a Novel Heart Failure Treatment services provided by Quotient Sciences

    Virtual BoothMenuQuotient Sciences
    First Subjects Dosing with VS-041 a Novel Heart Failure Treatment
    Full Screen View

    PDF Upload Sep, 2024
    News
    Quotient, Nanomerics Launch OC134 SUNLIGHT Study

    11 Dec 2024

    // PRESS RELEASE

    Quotient Sciences Wins 2024 Fierce CRO Awards Category

    11 Dec 2024

    // PRESS RELEASE

    Quotient Sciences Issues Inaugural ESG Report

    11 Dec 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Quotient rm 250x250

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
    Xls

    CATEGORY PAGE
    Menu

    Quotient Sciences

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI72998